| Nome |
# |
|
An unexpected complication of a percutaneous coronary angioplasty, file e383531d-621a-15e8-e053-a505fe0a3de9
|
108
|
|
The prognostic value of serial troponin measurements in patients admitted for COVID-19, file e383532c-ca80-15e8-e053-a505fe0a3de9
|
61
|
|
Pulmonary embolism in patients with COVID-19. characteristics and outcomes in the cardio-COVID Italy multicenter study, file e383532b-ebb0-15e8-e053-a505fe0a3de9
|
57
|
|
Isolated diastolic hypertension and target organ damage. findings from the STANISLAS cohort, file e383532c-b3a2-15e8-e053-a505fe0a3de9
|
56
|
|
Impact of sacubitril/valsartan on implantable defibrillator eligibility in heart failure. a real-world experience, file e383532d-2530-15e8-e053-a505fe0a3de9
|
51
|
|
Clinical and humoral determinants of congestion in heart failure. potential role of adiponectin, file e383532b-cb5b-15e8-e053-a505fe0a3de9
|
48
|
|
Dysregulation of epicardial adipose tissue in cachexia due to heart failure. the role of natriuretic peptides and cardiolipin, file e383532b-fa46-15e8-e053-a505fe0a3de9
|
48
|
|
The uraemic hypertensive patient. a therapeutic challenge-right you are (if you think so), file e383532b-ebb2-15e8-e053-a505fe0a3de9
|
44
|
|
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19. insights from the cardio-COVID-Italy multicenter study, file e383532d-23f3-15e8-e053-a505fe0a3de9
|
42
|
|
Echocardiographic visualization of retroaortic anomalous coronary artery, file e383532e-33eb-15e8-e053-a505fe0a3de9
|
42
|
|
Association of patient-reported outcomes and heart rate trends in heart failure. a report from the chiron project, file e383532b-ebad-15e8-e053-a505fe0a3de9
|
41
|
|
Multimodality imaging in sarcomeric hypertrophic cardiomyopathy: get it right…on time, file c427f2d0-418d-4af9-9809-b9dcb3dcd3d3
|
24
|
|
Myocardial metabolism evaluation and ketones utilization in the failing human heart, file e383531f-c5af-15e8-e053-a505fe0a3de9
|
23
|
|
Cenni di regolamentazione, classificazione e terapia farmacologica delle malattie dell’apparato cardiovascolare, file e383532c-2b44-15e8-e053-a505fe0a3de9
|
18
|
|
Cenni di regolamentazione, classificazione e terapia farmacologica delle malattie dell’apparato cardiovascolare, file e383532c-0fd5-15e8-e053-a505fe0a3de9
|
14
|
|
Cenni di regolamentazione, classificazione e terapia farmacologica delle malattie dell’apparato cardiovascolare, file e383532c-0fd6-15e8-e053-a505fe0a3de9
|
14
|
|
Tumori cardiaci, file e383531e-659a-15e8-e053-a505fe0a3de9
|
13
|
|
Combined role of troponin and natriuretic peptides measurements in patients with covid-19 (from the cardio-COVID-italy multicenter study), file e383532d-f52c-15e8-e053-a505fe0a3de9
|
13
|
|
Dyskalemia in people at increased risk for heart failure. findings from the heart 'OMics' in AGEing (HOMAGE) trial, file b36acb08-83a8-4dd9-a533-7330bbb18603
|
12
|
|
Ipertensione polmonare e cuore polmonare cronico, file e383532b-ced3-15e8-e053-a505fe0a3de9
|
11
|
|
Sodium–glucose co-transporter-2 inhibitors eligibility in patients with heart failure with reduced ejection fraction, file e383532c-b3a1-15e8-e053-a505fe0a3de9
|
10
|
|
Pulmonary vasculature responsiveness to phosphodiesterase-5a inhibition in heart failure with reduced ejection fraction. possible role of plasma potassium, file e383532e-e7cc-15e8-e053-a505fe0a3de9
|
10
|
|
Febbre reumatica acuta, file e383531e-6596-15e8-e053-a505fe0a3de9
|
9
|
|
Insufficienza cardiaca, file e383531e-6acc-15e8-e053-a505fe0a3de9
|
9
|
|
Ipertensione polmonare e cuore polmonare cronico, file e383532b-ced4-15e8-e053-a505fe0a3de9
|
9
|
|
Treating chronic kidney disease to reduce cardiovascular risk, file 571576e8-9bfe-476b-b7c8-806c90457eac
|
8
|
|
Ipertensione polmonare e cuore polmonare cronico, file e383532b-ced5-15e8-e053-a505fe0a3de9
|
8
|
|
Non-invasive measurement of right atrial pressure by near-infrared spectroscopy. preliminary experience. a report from the SICA-HF study, file e383531c-03bb-15e8-e053-a505fe0a3de9
|
7
|
|
Cenni di regolamentazione, classificazione e terapia farmacologica delle malattie dell’apparato cardiovascolare, file e383532c-284d-15e8-e053-a505fe0a3de9
|
7
|
|
Sodium-glucose co-transporter 2 inhibitors for the treatment of cardio-renal syndrome, file 5fcd50c5-1603-4f1c-96e2-6e48e2886b53
|
6
|
|
Effectiveness of the new generation transcatheter aortic valve in the real life studies. review and meta-analysis, file e3835329-85fb-15e8-e053-a505fe0a3de9
|
5
|
|
Ipertensione polmonare e cuore polmonare cronico, file e383532b-e935-15e8-e053-a505fe0a3de9
|
5
|
|
Wireless Telecardiology, file e383532b-f97d-15e8-e053-a505fe0a3de9
|
5
|
|
Wireless Telecardiology, file e383532c-3795-15e8-e053-a505fe0a3de9
|
5
|
|
Sex-related differences in patients with coronavirus disease 2019. results of the cardio-COVID-italy multicentre study, file e383532e-ca36-15e8-e053-a505fe0a3de9
|
5
|
|
The different pathways of epicardial adipose tissue across the heart failure phenotypes. from pathophysiology to therapeutic target, file 66a33d12-80cd-43c5-9cf4-74f8597a3179
|
4
|
|
Incremental value of gait speed in predicting prognosis of older adults with heart failure. insights from the IMAGE-HF study, file e383531d-38b6-15e8-e053-a505fe0a3de9
|
4
|
|
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era, file e3835328-1e5e-15e8-e053-a505fe0a3de9
|
4
|
|
Wireless Telecardiology, file e383532b-e06b-15e8-e053-a505fe0a3de9
|
4
|
|
Wireless Telecardiology, file e383532c-15d8-15e8-e053-a505fe0a3de9
|
4
|
|
A case of recurrent acute myocardial infarction, file e383532c-2842-15e8-e053-a505fe0a3de9
|
4
|
|
A walking thrombus, file e383532c-2ed8-15e8-e053-a505fe0a3de9
|
4
|
|
Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients. results of the Cardio-COVID-italy multicentre study, file e383532d-05d6-15e8-e053-a505fe0a3de9
|
4
|
|
Clinical and prognostic association of total atrial conduction time in patients with heart failure: a report from studies investigating co-morbidities aggravating heart failure, file e383532a-aaac-15e8-e053-a505fe0a3de9
|
3
|
|
Visit-to-visit blood pressure variation and outcomes in heart failure with reduced ejection fraction. findings from the eplerenone in Patients with systolic heart failure and mild symptoms trial, file e383532b-ceca-15e8-e053-a505fe0a3de9
|
3
|
|
Double-chambered left ventricle. an unusual finding in a middle-aged woman, file e383532c-201f-15e8-e053-a505fe0a3de9
|
3
|
|
Electrocardiographic voltage criteria in patients with hypertrophic cardiomyopathy, file e383532c-2eb9-15e8-e053-a505fe0a3de9
|
3
|
|
Electrocardiographic characteristics of right-bundle-branch-block premature ventricular complexes predicting absence of left ventricular scar in athletes with apparently structural normal heart, file 22979b4d-d356-4168-a5ee-1b5010a4c9b0
|
2
|
|
Pressure overload is associated with right ventricular dyssynchrony in heart failure with reduced ejection fraction, file 3bfc2680-44a8-402d-9bb5-716b925c9cbf
|
2
|
|
Optimal management of patients after acute coronary syndrome, file 3db7c5e8-c7b4-4593-814e-7027c47b3878
|
2
|
|
What proportion of patients with heart failure and preserved ejection fraction are eligible for empagliflozin, file ba920d55-d3c4-4a13-940a-95d58fc09f14
|
2
|
|
A strange thrombus in the left atrial appendage, file e383531d-6218-15e8-e053-a505fe0a3de9
|
2
|
|
Myocardial ketone body utilization in patients with heart failure. the impact of oral ketone ester, file e383532b-dd63-15e8-e053-a505fe0a3de9
|
2
|
|
Acute unloading effects of sildenafil enhance right ventricular–pulmonary artery coupling in heart failure, file e383532c-005b-15e8-e053-a505fe0a3de9
|
2
|
|
Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. results of the cardio-COVID-Italy multicentre study, file e383532c-1491-15e8-e053-a505fe0a3de9
|
2
|
|
Association of troponin levels with mortality in italian patients hospitalized with coronavirus disease 2019. results of a multicenter study, file e383532c-3647-15e8-e053-a505fe0a3de9
|
2
|
|
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients. results from an italian multicenter study, file e383532f-452a-15e8-e053-a505fe0a3de9
|
2
|
|
Letter by monzo and melenovsky regarding article, "metabolomic profiling of the effects of dapagliflozin in heart failure with reduced ejection fraction. DEFINE-HF", file f14a9aa4-4ff6-44ef-a5e3-80e6c722dcec
|
2
|
|
Role of aldosterone in mid- and long-term left ventricular remodelling after acute myocardial infarction. the REMI study, file 014831a8-40eb-49ec-b19b-7a56a883402b
|
1
|
|
High risk of stroke in patients with worsening heart failure, reduced ejection fraction, coronary heart disease and sinus rhythm. risk prediction score analysis from the COMMANDER-HF trial, file 06ad2a11-f8db-4379-95e2-d84cef1e24a2
|
1
|
|
Sodium-glucose co-transporter 2 inhibitors in heart failure. an updated evidence-based practical guidance for clinicians, file 080f3793-8505-4aa3-9811-f9090b4d64e3
|
1
|
|
Use of the win ratio analysis in critical care trials, file 0d2562b6-a1e7-46a3-b5ba-ef23eabbb5ba
|
1
|
|
The implantable cardiac monitor in heart failure patient. a possible new indication, file 1c1ef6dc-cacf-4c1b-8187-64e2a646201b
|
1
|
|
Bempedoic acid. what prospective uses, file 4fa05829-7e9c-4811-8b12-1ba1b2c6018e
|
1
|
|
Time to clinical benefit of eplerenone among patients with heart failure and reduced ejection fraction. a subgroups analysis from the EMPHASIS-HF trial, file 6c49af8f-ddfc-4377-b8f7-1cb9b234c154
|
1
|
|
Tackling the ReD(S) flag of congestion in heart failure, file a7470348-29c5-4fd4-ae0a-898b3a098403
|
1
|
|
Febbre Reumatica Acuta, file e3835316-8dfc-15e8-e053-a505fe0a3de9
|
1
|
|
Sacubitril/valsartan effect on left ventricular remodeling. the case of a super-responder, file e383532b-cec7-15e8-e053-a505fe0a3de9
|
1
|
| Totale |
924 |